Previous Article | Next Article 
Journal of Virology, October 1999, p. 8476-8484, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Low-pH-Dependent Fusion of Sindbis Virus with
Receptor-Free Cholesterol- and Sphingolipid-Containing
Liposomes
Jolanda M.
Smit,1
Robert
Bittman,2 and
Jan
Wilschut1,*
University of Groningen, Department of
Physiological Chemistry, 9713 AV Groningen, The
Netherlands,1 and Queens College of the
City University of New York, Department of Chemistry and
Biochemistry, Flushing, New York 113672
Received 14 April 1999/Accepted 8 July 1999
 |
ABSTRACT |
There is controversy as to whether the cell entry mechanism of
Sindbis virus (SIN) involves direct fusion of the viral envelope with
the plasma membrane at neutral pH or uptake by receptor-mediated endocytosis and subsequent low-pH-induced fusion from within acidic endosomes. Here, we studied the membrane fusion activity of SIN in a
liposomal model system. Fusion was followed fluorometrically by
monitoring the dilution of pyrene-labeled lipids from biosynthetically labeled virus into unlabeled liposomes or from labeled liposomes into
unlabeled virus. Fusion was also assessed on the basis of degradation
of the viral core protein by trypsin encapsulated in the liposomes. SIN
fused efficiently with receptor-free liposomes, consisting of
phospholipids and cholesterol, indicating that receptor interaction is
not a mechanistic requirement for fusion of the virus. Fusion was
optimal at pH 5.0, with a threshold at pH 6.0, and undetectable at
neutral pH, supporting a cell entry mechanism of SIN involving fusion
from within acidic endosomes. Under optimal conditions, 60 to 85% of
the virus fused, depending on the assay used, corresponding to all of
the virus bound to the liposomes as assessed in a direct binding assay.
Preincubation of the virus alone at pH 5.0 resulted in a rapid loss of
fusion capacity. Fusion of SIN required the presence of both
cholesterol and sphingolipid in the target liposomes, cholesterol being
primarily involved in low-pH-induced virus-liposome binding and the
sphingolipid catalyzing the fusion process itself. Under low-pH
conditions, the E2/E1 heterodimeric envelope glycoprotein of the virus
dissociated, with formation of a trypsin-resistant E1 homotrimer, which
kinetically preceded the fusion reaction, thus suggesting that the E1
trimer represents the fusion-active conformation of the viral spike.
 |
INTRODUCTION |
Sindbis virus (SIN) is the prototype
member of the genus Alphavirus of the family
Togaviridae. Alphaviruses are structurally well-defined
viruses which contain three major proteins, the capsid protein, C, and
two envelope glycoproteins, E1 and E2 (27, 54). The
glycoproteins are organized in 80 hetero-oligomeric spikes; a single
spike consists of a trimer of E2/E1 heterodimers. In the infected cell,
the spike heterodimer is assembled in the endoplasmic reticulum as a
PE2/E1 heterodimer in which PE2 is the precursor of the E2. The PE2/E1
heterodimer is subsequently transported through the Golgi and the
trans-Golgi network to the plasma membrane. Just before the appearance
of the spike on the cell surface, the PE2 precursor is cleaved into E2
and E3 by a cellular furin-like protease, resulting in the formation of
the mature E2/E1 form of the heterodimer (33). In some
alphaviruses, including SIN, the E3 peptide is released from the virus
particles (37), whereas in others, such as Semliki Forest
virus (SFV), E3 remains associated with the E2/E1 heterodimer.
The E2/E1 heterodimer mediates the infectious entry of SIN into its
host cell. The initial step in cell entry is the interaction of the
virus with a cellular receptor. A high-affinity receptor for binding of
SIN to rodent and monkey cells has been identified as the 67-kDa
protein laminin (57). Recently, it has been shown that the
widely expressed glycosaminoglycan heparan sulfate may also be involved
in the binding of SIN to cells (6, 30). It is the E2
component of the alphavirus spike that is primarily involved in
receptor interaction (48, 50).
Being an enveloped virus, SIN infects its host cells by a membrane
fusion reaction. In principle, fusion of enveloped viruses may occur
either at the plasma membrane or from within the endosomal cell
compartment after internalization of the virus particles through
receptor-mediated endocytosis. In the process of plasma membrane
fusion, the interaction of the virus with a cellular receptor mediates
the conformational changes within the viral spike protein that are
required for the fusion reaction, fusion occurring at the neutral pH of
the extracellular environment. In the process of virus cell entry
through receptor-mediated endocytosis, it is generally the mildly
acidic pH within the lumen of the endosomes that triggers the membrane
fusion reaction.
There is considerable controversy with regard to the cell entry
mechanism of SIN. Several lines of evidence suggest that SIN may fuse
directly at the cell plasma membrane at neutral pH, mediated by
interaction of the viral spike with its cellular receptor. For example,
SIN has been observed to infect cells treated with weak bases, like
chloroquine and ammonium chloride, which raise the pH of endosomes, as
evidenced by the translation of viral RNA in the cell cytosol (7,
8). This suggests that the infection process of SIN does not
involve acidic endosomes. Accordingly, SIN has been found to infect a
Chinese hamster ovary (CHO) cell mutant, temperature sensitive for
endosome acidification (14), although earlier observations
involving similar CHO cell mutants had suggested that a lack of
endosome acidification does inhibit infection (39, 47).
Furthermore, Flynn et al. (17) detected conformational
changes within the glycoproteins of SIN upon interaction of the virus
with cells at neutral pH and suggested that the virus-receptor interaction induces the fusion-active conformation of the viral spike.
Abell and Brown (1) then proposed a model for SIN entry in
which the virus-receptor interaction enhances thiol-disulfide exchange
reactions reorganizing the viral spike protein, allowing the virus to
penetrate cells by direct fusion with the plasma membrane.
On the other hand, early (15) and quite recent evidence
supports an endocytic mechanism for cell entry by SIN. In fact, while
the present study was in progress, DeTulleo and Kirchhausen (12) reported that infection of cells by SIN is inhibited by dominant-negative mutant forms of dynamin, which block the budding of
clathrin-coated pits, thus suggesting that SIN infects its host cells
by clathrin-mediated endocytosis. Furthermore, Glomb-Reinmund and
Kielian (20) published a study also providing evidence for cell entry of SIN through receptor-mediated endocytosis and fusion from
within acidic endosomes. These authors made a direct comparison between
SIN and SFV, because it is well established that SFV enters cells
through an endocytic mechanism (21-24, 27, 35, 36). Upon
exposure of SFV to low pH, the viral E2/E1 heterodimeric glycoprotein
dissociates and a trypsin-resistant homotrimer of the fusion protein E1
(19, 31) is formed, which presumably represents the
fusion-active conformation of the viral spike (4, 25, 29, 55,
56). SFV is also capable of fusing with liposomes in a mildly
acidic environment, indicating that the sole trigger for fusion is low
pH (4, 25, 42, 55, 58, 59).
Here, we studied fusion of SIN in a liposomal model system, using virus
biosynthetically labeled with pyrene phospholipids (4, 42, 55,
59). It is demonstrated that the virus fuses rapidly with
liposomes lacking a specific receptor, indicating that receptor binding
is not essential for triggering the fusion reaction. Fusion is strictly
dependent on low pH, consistent with cellular entry of SIN, like that
of SFV, through acidic endosomes.
 |
MATERIALS AND METHODS |
Lipids.
Phosphatidylcholine (PC) from egg yolk,
phosphatidylethanolamine (PE) prepared by transphosphatidylation of egg
PC, and sphingomyelin (SPM) from egg yolk were obtained from Avanti
Polar Lipids (Alabaster, Ala.). High-purity cholesterol (Chol) was a
generous gift from Solvay Pharmaceuticals (Weesp, The Netherlands). The
fluorescent probes 16-(1-pyrenyl)hexadecanoic acid (pyrene fatty acid)
and 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine (pyrPC) were purchased from Molecular Probes (Eugene, Oreg.).
Cells and virus.
SIN strain AR339 was a generous gift from
Diane E. Griffin (Johns Hopkins University, Baltimore, Md.). The virus
was propagated on baby hamster kidney cells (BHK-21). The cells were
cultured in Glasgow's modification of Eagle's minimal essential
medium (Gibco/BRL, Breda, The Netherlands), supplemented with 5% fetal calf serum, 10% tryptose phosphate broth, 200 mM glutamine, 25 mM
HEPES, and 7.5% sodium bicarbonate. Pyrene-labeled SIN was isolated
from the medium of infected BHK-21 cells, cultured beforehand in the
presence of pyrene fatty acid, essentially as described before for SFV
(4, 42, 55, 59). Briefly, BHK-21 cells, grown for 48 h
in medium containing 15 µg of pyrene fatty acid per ml, were infected
with SIN at a multiplicity of infection of 4. At 24 h
postinfection, the pyrene-labeled SIN particles were harvested from the
medium by ultracentrifugation in a Beckman type 19 rotor for 2.5 h
at 100,000 × g at 4°C. The virus particles were
further purified by ultracentrifugation on a 20 to 50% (wt/vol) sucrose density gradient in a Beckman SW41 rotor for 16 h at
100,000 × g at 4°C.
[35S]methionine-labeled SIN and unlabeled SIN were
produced in a similar fashion (4, 42, 55, 59). The purity of
the SIN particles was evaluated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The viral
phospholipid was determined by phoshate analysis (3). The
protein concentration was determined according to Peterson
(44). The infectivity of the virus preparation was
determined by titration on BHK-21 cells in 96-well plates.
Liposomes.
Large unilamellar vesicles were prepared by a
freeze-thaw extrusion procedure (10, 40, 42, 59). Briefly,
lipid mixtures were dried from a chloroform-methanol solution under a
stream of nitrogen and further dried under vacuum for at least 1 h. The lipid mixtures were hydrated in 5 mM HEPES-150 mM NaCl-0.1 mM EDTA (pH 7.4) (HNE) and subjected to five cycles of freezing and thawing. Subsequently, lipid mixtures were extruded 21 times through a
Unipore polycarbonate filter with a pore size of 0.2 µm (Nuclepore, Inc., Pleasanton, Calif.) in a LiposoFast mini-extruder (Avestin, Ottawa, Canada). Smaller liposomes were prepared by extrusion an
additional 81 times through two Unipore polycarbonate filters, each
with a pore size of 0.05 µm. The size of the liposomes was determined
by quasi-elastic light scattering analysis in a submicron particle
sizer model 370 (Nicomp Particle Sizing Systems, Santa Barbara,
Calif.). Liposomes consisted of PC/PE/SPM/Chol (molar ratio,
1:1:1:1.5), PC/PE/SPM (molar ratio, 1:1:1), PC/PE/Chol (molar ratio,
1:1:1), PC/PE (molar ratio, 1:1), or PC/pyrPC/PE/SPM/Chol (molar ratio,
0.85:0.15:1:1:1.5).
Trypsin-containing liposomes were also prepared by freeze-thaw
extrusion, but in this case, the lipids were dispersed in HNE in the
presence of 10 mg of trypsin (Boehringer, Mannheim, Germany) per ml.
The liposomes were extruded 21 times through a filter with a pore size
of 0.2 µm. The trypsin-containing liposomes were separated from free
trypsin by gel filtration on a Sephadex G-100 column in HNE. The
phospholipid concentration of liposome preparations was determined by
phosphate analysis (3).
Fusion assays.
Fusion of pyrene-labeled SIN with liposomes
was monitored continuously in an AB2 fluorometer (SLM/Aminco, Urbana,
Ill.). Pyrene-labeled SIN (0.5 µM viral phospholipid) and liposomes
(200 µM phospholipid) were mixed in a quartz cuvette of the
fluorometer in a final volume of 0.665 ml in HNE, unless indicated
otherwise. The contents of the cuvette were stirred magnetically and
thermostated at the desired temperature. After 1 min of incubation,
fusion was triggered by the addition of 35 µl of 0.1 M MES
(morpholinoethanesulfonic acid)-0.2 M acetic acid, pretitrated with
NaOH to achieve the final desired pH. The fusion scale was calibrated
such that 0% fusion corresponded to the initial excimer fluorescence
value. The 100% fusion value was obtained through the addition of 35 µl of 0.2 M octaethyleneglycol monododecyl ether
(C12E8; Fluka Chemie AG, Buchs, Switzerland) to
achieve an infinite dilution of the probe (4, 42, 55, 59).
The initial rate of fusion was determined from the tangent to the first
part of the curve. The extent of fusion was determined 60 s after acidification.
Fusion of pyrPC-labeled liposomes with SIN was measured under the same
conditions, essentially as described before for SFV
(
32) and
vesicular stomatitis virus (
41). For these experiments,
liposomes were prepared, with a diameter of 70 nm (see above).
In the
fusion reaction, liposomes (2 µM liposomal phospholipids)
were mixed
with SIN (10 µM viral phospholipid), unless indicated
otherwise.
Transfer of the viral nucleocapsid to the liposomal lumen during
SIN-liposome fusion was measured as the degradation of the
viral capsid
protein by trypsin, initially encapsulated in the
liposomes (
42,
58,
59). Briefly, a trace amount of
[
35S]methionine-labeled virus and unlabeled virus (final
concentration
of 0.5 µM viral phospholipid) were mixed with
trypsin-containing
liposomes (200 µM phospholipid) in the presence of
125 µg of trypsin
inhibitor (Boehringer) per ml in HNE. The mixture
was acidified,
under continuous stirring, to the desired pH with 0.1 M
MES-0.2
M acetic acid, as above. After 30 s, samples were
neutralized
by the addition of a pretitrated volume of NaOH. The
samples were
further incubated for 1 h at 37°C and subsequently
analyzed by
SDS-PAGE. Gels were incubated for 30 min in 1 M sodium
salicylate
and dried. Protein bands were visualized by autoradiography.
Quantification
of the capsid protein was done by phosphorimaging
analysis using
Image Quant 3.3 software (Molecular Dynamics, Sunnyvale,
Calif.).
Virus-liposome binding assay.
Virus-liposome binding was
assessed by a coflotation assay, as described before (4, 9, 40,
42, 55, 59). The reactions were carried out under the same
experimental conditions as those in the fusion experiments. A trace
amount of [35S]methionine-labeled virus and unlabeled
virus (final concentration of 0.5 µM viral phospholipid) were mixed
with liposomes (200 µM phospholipid). The mixture was acidified,
under continuous stirring, to the desired pH with 0.1 M MES-0.2 M
acetic acid, as above. After 60 s, samples were neutralized
through the addition of a pretitrated volume of NaOH. Subsequently, 0.1 ml of the reaction mixture was added to 1.4 ml of 50% (wt/vol) sucrose
in HNE. On top of this, 2.0 ml of 20% (wt/vol) sucrose and 1.0 ml of
5% (wt/vol) sucrose in HNE were layered. After centrifugation in a
Beckman SW50 rotor at 150,000 × g for 2 h at
4°C, the gradient was fractionated in 10 samples, starting from the
top. The distribution of the viral radioactivity was quantified by
liquid scintillation analysis. The radioactivity in the top four
fractions, relative to the total amount of radioactivity, was taken as
a measure for SIN-liposome binding.
Analysis of the conformational changes in the viral spike
protein.
The conformational changes occurring in the viral spike
protein were examined under the same conditions as in the fusion and binding experiments. After low-pH treatment, samples were neutralized by addition of a pretitrated volume of NaOH, solubilized in SDS-PAGE buffer, and analyzed by SDS-PAGE. For the appearance of
trypsin-resistant forms of E1, samples were incubated in the presence
of 200 µg of trypsin per ml for 15 min at 37°C. Subsequently,
samples were solubilized in SDS-PAGE sample buffer, heated for 4 min at
100°C, and analyzed by SDS-PAGE. Gels were further incubated for 30 min in 1 M sodium salicylate and dried. Visualization of the bands was
done by autoradiography. Quantification of the trimeric form of E1 was
done, using phosphorimaging analysis, as described above, by relating
the intensity of the trimeric E1 to the total intensity of monomeric
E1, E2, and trimeric E1, corrected for the contribution of E2 on the
basis of the relative numbers of methionine residues in the E1 and E2 proteins.
 |
RESULTS |
Characterization of pyrene-labeled SIN.
In this study, we used
SIN, biosynthetically labeled with the fluorescent probe pyrene. The
labeling procedure involves production of the virus on BHK-21 cells
cultured beforehand in the presence of pyrene fatty acid (4, 10,
42, 59). Newly formed virus particles thus carry the pyrene probe
in their membrane phospholipids. In order to examine the potential
effect of pyrene incorporation in the viral membrane on the infectivity
of the virus, the specific infectivities of pyrene-labeled and
unlabeled virus were determined. Virus was isolated and purified from
the medium of infected pyrene-labeled or unlabeled BHK-21 cells, as
described in Materials and Methods. Analysis by SDS-PAGE demonstrated
that the virus preparations were pure, as evidenced by the presence of
just the three major structural proteins, E1, E2, and C (results not
shown). Subsequent determination of the viral titer and protein
concentration showed that for pyrene-labeled SIN the infectious unit to
particle ratio was 1/13 under the conditions of the experiment, while
for unlabeled control virus the corresponding ratio was 1/12. For the
calculation, a theoretical amount of 5.45 · 10
17 g
of protein per virus particle was used. Since the infectious unit to
particle ratios of unlabeled and pyrene-labeled SIN appeared to be very
similar, indicating that pyrene labeling has no effect on the
infectivity of the virus.
Low-pH-dependent fusion of pyrene-labeled SIN with liposomes.
Fusion of pyrene-labeled SIN was measured in a liposomal model system
(4, 42, 55, 59). The pyrene probe forms excimers with a
fluorescence emission maximum at 480 nm, about 100 nm higher than the
fluorescence maximum of pyrene monomers. Pyrene excimer formation is
dependent on the average distance between the probe molecules. Thus, in
the virus membrane, the excimer fluorescence intensity is proportional
to the surface density of pyrene-labeled phospholipid molecules
(18, 43). Upon fusion of pyrene-labeled virus particles with
liposomes, the pyrene phospholipids will be diluted into the liposomes,
resulting in a decrease in the pyrene excimer fluorescence intensity,
which can be monitored continuously. For this assay, liposomes were
prepared with an average diameter of 200 nm. The diameter of the viral
membrane (excluding the glycoproteins) is about 50 nm. Therefore, upon fusion of a virus particle with a liposome, the pyrene phospholipids dilute by at least an order of magnitude. In the fusion reaction, pyrene-labeled SIN (0.5 µM viral phospholipid) was mixed with an
excess of liposomes (200 µM phospholipid) consisting of
PC/PE/SPM/Chol with a molar ratio of 1:1:1:1.5.
Figure
1A presents the fusion kinetics of
pyrene-labeled SIN with liposomes. At pH 5.0, the virus fused rapidly
and efficiently
with the liposomes. By contrast, at pH 7.4, no
detectable fusion
occurred. Furthermore, the fluorescence intensity of
pyrene-labeled
SIN at low pH in the absence of target liposomes
remained constant,
demonstrating that the decrease in excimer
fluorescence intensity
observed in the presence of liposomes was due to
dilution of the
probe from the viral membrane into the liposomal
membrane. At
pH 5.75, an intermediate extent of fusion was observed
with the
initial rate substantially lower than that at pH 5.0.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Low-pH-dependent fusion of pyrene-labeled SIN with
liposomes. Fusion was measured on-line at 37°C as a decrease of viral
pyrene excimer fluorescence, as described in Materials and Methods.
Final virus and liposome concentrations were 0.5 and 200 µM (membrane
phospholipid), respectively. Liposomes consisted of PC/PE/SPM/Chol
(molar ratio, 1:1:1:1.5). (A) Curves: a, pH 5.0; b, pH 5.75; c, pH 7.4;
d, pH 5.0, without liposomes. (B) The initial rate of fusion (solid
circles) was determined from the tangent to the first part of the
curve. The extent of fusion (squares) was determined 60 s after
acidification.
|
|
Figure
1B shows the detailed pH dependence of SIN fusion with
PC/PE/SPM/Chol liposomes. Optimal fusion in terms of both initial
rate
and final extents was observed at pH 5.0, with a threshold
at pH 6.0. Under optimal conditions, a decrease of excimer fluorescence
intensity
by approximately 60% was observed. This corresponds
to fusion of a
minimum of 60% of the virus particles, since each
fusion event is
expected to result in an extensive dilution of
the pyrene probe (see
above). However, upon fusion of a virus
particle with a relatively
small liposome, a residual excimer
fluorescence intensity may remain.
This implies that the level
of 60% may represent an underestimate of
the actual extent of
fusion. The initial rate of fusion at pH 5.0 was
very fast, corresponding
to 20 to 25% of the virus particles fusing
within the first second
after the acidification of the virus-liposome
mixture. At pH values
higher or lower than the optimal pH 5.0, fusion
exhibited slower
kinetics and lower
extents.
Fusion required an excess of liposomes, leading to an apparent
saturation at 100 to 150 µM phospholipid (results not shown).
In
principle, it is possible that with liposome concentrations
increasing
beyond the saturating level, a single virus particle
will fuse
simultaneously with multiple liposomes. However, this
is not expected
to result in a significant further decrease of
the fluorescence signal
since, in general, a single fusion event
already produces a dilution of
the pyrene probe by at least an
order of magnitude, as indicated
above.
Fusion of unlabeled SIN with pyrene-labeled liposomes.
We also
used a reverse variant of the pyrene lipid mixing assay in order to
ascertain that the fusion signal seen in the experiments of Fig. 1 and
2 was not due to a peculiarity of the
pyrene-labeled virus used in those experiments. In the reverse assay,
an excess of unlabeled SIN was incubated with pyrPC-labeled liposomes,
and dilution of the probe from the liposomal membrane into the viral membrane was assessed. For the fusion reaction, liposomes were prepared
with a diameter of 70 nm. Given the diameter of the viral membrane, 50 nm, fusion of a liposome with a single virus particle thus is expected
to result in a one-third enlargement of the liposomal membrane, with a
concomitant decrease of the pyrene excimer fluorescence by 33%.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Low-pH-dependent fusion of SIN with pyrPC-labeled
liposomes. Fusion was measured on-line at 37°C as a decrease of
liposomal excimer fluorescence, as described in Materials and Methods.
Fusion of pyrPC-labeled liposomes (2 µM liposomal phospholipid) with
SIN (10 µM viral phospholipid) was measured at pH 5.0, unless
indicated otherwise. Liposomes consisted of PC/pyrPC/PE/SPM/Chol (molar
ratio, 0.85:0.15:1.0:1.0:1.5). (A) Curves: a, pH 5.0; b, pH 7.4; c, pH
5.0, but in the absence of SIN. (B) The final extent of excimer
fluorescence decrease (squares) was determined, 60 s after
acidification, as a function of the viral phospholipid concentration.
|
|
Figure
2A shows that pyrPC-labeled liposomes consisting of
PC/PE/SPM/Chol under low pH conditions fused efficiently with unlabeled
SIN. At pH 5.0, a decrease in pyrene excimer fluorescence by about
38%
in 60 s was observed. Again, at neutral pH, there was no
significant
fusion. Furthermore, pyrPC-labeled liposomes in the absence
of
virus did not exhibit any change in fluorescence intensity upon
acidification to pH 5.0.
In Fig.
2B, the extent of excimer fluorescence decrease is presented as
a function of the virus concentration. When a fixed
concentration of
pyrPC-labeled liposomes (2 µM phospholipid, corresponding
to 4 × 10
10 particles per ml) was incubated with increasing
virus concentrations,
the extent of the decrease in excimer
fluorescence intensity increased
in a biphasic manner. At the
extrapolated inflection point, the
extent of excimer fluorescence
decrease was 32%, which is very
close to the theoretical value, 33%,
expected for one virus particle
fusing with a single liposome. The
inflection occurred at a virus
concentration of 2.5 µM viral
phospholipid, corresponding to 10
11 particles per ml. Thus,
we conclude that on average each liposome
fuses at least once with a
single virus particle at a virus-to-liposome
particle ratio of
approximately 2.5. After the inflection point,
the extent of excimer
fluorescence decrease continued to increase,
consistent with one
liposome fusing simultaneously with more than
one virus particle.
Unlike the condition of a labeled virus particle
fusing with a
considerably larger liposome, fusion of a labeled
70-nm liposome with
multiple smaller virus particles is expected
to produce a significantly
greater dilution of the probe than
fusion of one such liposome with a
single virus
particle.
Contents mixing during SIN-liposome fusion.
In the above
experiments, the detection of SIN-liposome fusion was based on lipid
mixing assays. A more stringent criterion for fusion involves the
mixing of the internal contents of the virus with the liposomal lumen.
To demonstrate contents mixing in the SIN-liposome system, we used an
assay involving [35S]methionine-labeled virus and
trypsin-containing liposomes (42, 58, 59). Fusion was
assayed as the degradation of the viral capsid protein in the presence
of an excess of trypsin inhibitor in the medium. As shown in Fig.
3A, incubation of SIN with an excess of
trypsin-containing PC/PE/SPM/Chol liposomes at pH 5.0 resulted in the
degradation of a substantial fraction of the capsid protein. At neutral
pH, no degradation of the capsid protein was detected. Furthermore,
incubation of virus at pH 5.0 with empty liposomes under otherwise the
same conditions did not result in degradation of the capsid protein
either. In these controls, the ratio of radioactivity in the capsid
band relative to the total radioactivity, as determined by
phosphorimaging, was close to 0.4, as expected on the basis of the
number of methionine residues in the viral structural proteins
(46). To exclude the possibility that the amount of trypsin
was limiting under the conditions of the experiment, Triton X-100 was
added to the reaction mixture in the absence of trypsin inhibitor. This
resulted in complete degradation of the capsid protein, demonstrating
that the amount of trypsin was not limiting in the assay (results not
shown).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 3.
Transfer of the viral capsid into the liposomal lumen
assayed as the degradation of the viral capsid protein. Fusion of
[35S]methionine-labeled SIN (0.5 µM viral phospholipid)
with trypsin-containing PC/PE/SPM/Chol liposomes (200 µM liposomal
phospholipid) in the presence of trypsin inhibitor in the external
medium at 37°C was determined, as described in Materials and Methods.
(A) Visualization of the protein bands by autoradiography. Lanes: a,
trypsin-containing liposomes at pH 5.0; b, trypsin-containing liposomes
at pH 7.4; c, empty liposomes at pH 5.0. (B) Quantification of the
extent of capsid protein degradation as a result of virus incubation
with trypsin-containing liposomes at different pH values as determined
by phosphorimaging analysis.
|
|
Figure
3B presents a quantification by phosphorimaging analysis of the
extent of capsid protein degradation as a function
of pH. At pH 5.0, approximately 85% of the capsid protein was
degraded, while at pH 5.0 and pH 5.75 the corresponding numbers
were 64 and 41%, respectively.
It appears, therefore, that qualitatively
the pH dependence of the
SIN-liposome fusion process is the same
in the contents mixing assay
and the lipid mixing assay. However,
the extent of fusion as assessed
by the trypsin assay was consistently
slightly higher than that
determined by the pyrene assay. This
underlines the conclusion that the
pyrene assay presumably underestimates
the extent of fusion, as
indicated above. In addition, there may
be small differences in fusion
capacity between individual virus
batches.
Taken together, the results obtained with the lipid mixing assays
involving either pyrene-labeled SIN or pyrene-labeled liposomes,
and
the results of the contents mixing assay demonstrate conclusively
that
SIN fuses rapidly and almost quantitatively with receptor-free
liposomes in a strictly low-pH-dependent
manner.
Chol and SPM are required for low-pH-induced SIN-liposome
fusion.
A characteristic feature of the fusion of SFV is the
specific requirement of Chol and SPM in the target membrane (4,
26, 42, 45, 55, 58, 59). Because of the similarity between SFV
and SIN, it was of interest to determine whether SIN exhibits the same
lipid dependence. As shown in Fig. 4,
liposomes of various lipid compositions were examined in order to
determine the lipid dependence of SIN fusion. Under low-pH conditions,
pyrene-labeled SIN fused efficiently with liposomes consisting of
PE/PC/SPM/Chol. However, SIN was unable to fuse with liposomes
consisting of either PE/PC/SPM or PE/PC/Chol. When either PC or PE or
both were omitted from the liposomes, SPM and Chol being maintained,
sustained fusion activity was observed (results not shown). This
demonstrates that the presence of both Chol and SPM in the target
membrane is essential for SIN-liposome fusion at low pH.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of the target membrane lipid composition on
fusion of pyrene-labeled SIN with liposomes. Fusion of pyrene-labeled
SIN with liposomes of different lipid compositions was measured at pH
5.0 at 37°C, as described in the legend for Fig. 1. Curves: a,
PC/PE/SPM/Chol (molar ratio, 1.0:1.0:1.0:1.5) liposomes; b, PC/PE/SPM
(molar ratio, 1.0:1.0:1.0) liposomes; c, PC/PE/Chol (molar ratio,
1.0:1.0:1.0) liposomes.
|
|
Low-pH-dependent binding of SIN to liposomes.
The first step
in low-pH-induced SIN-liposome fusion is binding of the virus to the
liposomes. Various lipid compositions in the liposomes were examined in
order to determine the influence of the target membrane lipids on the
binding of SIN to liposomes. Briefly, a mixture of
[35S]methionine-labeled SIN, unlabeled virus, and
liposomes was incubated at pH 5.0 or pH 7.4. After 60 s, the pH of
the reaction mixture was neutralized by the addition of NaOH.
Liposome-bound virus was separated from unbound virus by flotation on a
sucrose density gradient. The results are shown in Fig.
5. Binding of SIN to liposomes was
strictly dependent on acidic pH. At neutral pH, there was negligible
interaction between the virus and the liposomes. At pH 5.0, we found
72% of the virus particles bound to liposomes consisting of
PE/PC/SPM/Chol. By comparing the fusion data in Fig. 1 and 3 with the
binding data obtained here, we conclude that all of the particles that
bound to the liposomes under these conditions also fused. In the
trypsin assay, we even observed a slightly higher extent of capsid
protein degradation at pH 5.0 than of virus-liposome binding under the
same conditions. This is presumably due to minor differences between
individual virus batches. The association of SIN with PE/PC/Chol
liposomes was less efficient, resulting in 25% binding. However, these
virus particles only bound to the liposomes but did not fuse, fusion being undetectable with liposomes lacking SPM (Fig. 4). SIN bound very
poorly to liposomes consisting of either PC/PE/SPM or PC/PE. These
results indicate that cholesterol promotes binding of the virus to the
liposomes but is not sufficient for extensive irreversible binding, as
seen under comparable conditions with SFV (40). This
indicates that in the case of SIN both Chol and SPM are required for
efficient irreversible binding (and fusion) of the virus to the
liposomes.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Influence of Chol and SPM on pH-dependent binding of SIN
to liposomes. SIN (trace of [35S]methionine-labeled virus
and unlabeled virus [0.5 µM phospholipid]) was incubated with
liposomes (200 µM liposomal phospholipid) at pH 5.0 or pH 7.4 at
37°C. Binding of SIN to liposomes was determined by coflotation
analysis on sucrose density gradients, as described in Materials and
Methods. Bars: a, PC/PE/SPM/Chol (molar ratio, 1.0:1.0:1.0:1.5)
liposomes; b, PC/PE/Chol (molar ratio, 1.0:1.0:1.0) liposomes; c,
PC/PE/SPM (molar ratio, 1.0:1.0:1.0) liposomes; d, PC/PE (molar ratio,
1.0:1.0) liposomes.
|
|
Inactivation of SIN fusion capacity through preexposure of the
virus alone to low pH.
It has been suggested recently that
preexposure of SIN to low pH during freezing of the virus in medium or
phosphate-buffered saline (PBS), which results in a transient lowering
of the pH, may activate the viral fusion capacity, thus possibly
explaining observations suggesting fusion of the virus under neutral pH
conditions at the level of the target cell plasma membrane (12,
16). The implicit assumption underlying this suggestion is that
virus activated by preexposure to low pH would remain fusion active for
a significant period of time, e.g., several minutes. In this perspective, we analyzed whether preexposure to low pH of SIN alone
results in sustained fusion capacity. Notably, incubation of SFV at an
acidic pH in the absence of target membranes results in a very rapid
loss of the fusion capacity of the virus (4).
Pyrene-labeled SIN was incubated at pH 5.0 at 37°C in the absence of
target liposomes for various periods of time. Subsequently,
PC/PE/SPM/Chol liposomes were added and the remaining fusion activity
was determined. Figure
6 shows that such
a preincubation of the
virus alone leads to a rapid loss of fusion
activity, in agreement
with earlier observations of others
(
13). Preincubation of SIN
at pH 5.0 for 20 s resulted
in a 50% reduction of fusion, while
a preincubation for 2 to 3 min
resulted in an essentially complete
loss of fusion capacity. This
indicates that fusion activation
of SIN triggered by low pH is of a
transient nature, resulting
in a rapid subsequent irreversible loss of
fusion capacity.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Inactivation of viral fusion capacity due to the
preexposure of SIN alone to acidic pH. Fusion was measured on-line at
37°C as a decrease of viral pyrene excimer fluorescence, as described
in the legend for Fig. 1. Pyrene-labeled SIN (0.5 µM viral
phospholipid) was incubated at pH 5.0, and at the indicated time
periods, liposomes (200 µM phospholipid) consisting of PC/PE/SPM/Chol
(molar ratio, 1:1:1:1.5) in pH 5.0 buffer were added to the reaction
mixture; subsequently, fusion was measured. The final extents of
fusion, at 60 s after acidification of the liposomes, were related
to the extent of fusion of an untreated control (the absolute extent
for fusion of this control was 62%).
|
|
Next, we exposed SIN to low pH by slowly or rapidly freezing the virus
in cell culture medium without HEPES buffer or in PBS,
subsequently
assessing the capacity of the virus to fuse with
liposomes at neutral
pH. There was no detectable fusion under
these conditions (results not
shown).
Conformational changes of the viral spike protein under fusion
conditions.
Finally, we investigated the structural changes
occurring in the SIN envelope glycoprotein occurring in the presence of
target liposomes under fusion conditions, in an attempt to determine the viral spike conformational requirements for fusion. To this end,
the kinetics of fusion and the kinetics of the viral spike conformational changes were determined under comparable conditions. A
complicating factor in this respect relates to the extremely high rates
of the fusion reaction upon acidification of a SIN-liposome mixture at
37°C to the optimal pH for fusion (pH 5.0). Therefore, for
determination of the relative kinetics of virus-liposome fusion and the
occurrence of spike conformational changes, we chose a pH of 5.75 and a
temperature of 20°C, conditions under which the kinetics of the
process are slowed down considerably. Also, the fusion process at pH
5.75 at 20°C exhibited a lag phase of approximately 9 to 10 s
preceding the onset of fusion (results not shown; see Fig. 8).
Furthermore, the final extent of fusion was reduced.
Figure
7 shows the time course of the
structural changes occurring in the viral spike protein. Briefly,
mixtures of [
35S]methionine-labeled SIN, unlabeled SIN,
and liposomes were incubated
at pH 5.75 at 20°C. At the indicated
time points, the mixtures
were neutralized by the addition of a
pretitrated volume of NaOH.
Subsequently, the samples were analyzed by
SDS-PAGE (Fig.
7A).
Besides E1 and E2, another protein band became
apparent. Determination
of the size of the protein, in which a set of
marker proteins
was used, showed that the protein band had a molecular
weight
of 150, indicating that a trimer of E1 was formed. To analyze
the formation of a trypsin-resistant form of the viral spike protein,
we incubated the mixtures in the presence of trypsin (200 µg/ml)
at
37°C. After heating of the trypsin-treated samples for 5 min
at
100°C, they were analyzed by SDS-PAGE. Figure
7B shows the
time
course for the appearance of a trypsin-resistant phenotype
of the E1
protein. Since the kinetics of the E1 trimer formation
and of the
appearance of the trypsin-resistant phenotype of the
E1 were similar,
it is likely that it is in fact the trimerization
of E1 that renders it
trypsin resistant.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 7.
Kinetics of the structural changes in the SIN spike
protein after incubation at low pH. SIN (trace of
[35S]methionine-labeled virus and unlabeled virus [0.5
µM phospholipid]) was incubated with liposomes (200 µM liposomal
lipid) consisting of PC/PE/SPM/Chol (molar ratio, 1.0:1.0:1.0:1.5) at
pH 5.75 at 20°C. At the indicated time points, samples were
neutralized and analyzed for the appearance of E1 trimers (A) and for a
trypsin-resistant form of E1 (B) by SDS-PAGE, as described in Materials
and Methods.
|
|
Figure
8 presents a kinetic comparison of
SIN-liposome binding, E1 trimerization, and fusion during the initial
60 s following
a pH jump from 7.4 to 5.75 at 20°C. The extents
of virus-liposome
binding, fusion, and E1 trimerization at 60 s were
30, 14, and
56%, respectively. This indicates that not all of the
virus bound
to the liposomes under these suboptimal conditions also
fused.
In fact, a fraction of the virus initially bound to the
liposomes
may subsequently dissociate, possibly explaining the
relatively
high degree of E1 trimerization. We were not able to detect
differences
between the kinetics of virus-liposome binding and those of
E1
trimerization. However, fusion proceeded with a significant delay
after the virus-liposome binding and E1 trimerization processes.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 8.
Sequence of events after acidification of a SIN-liposome
mixture. The kinetics of SIN-liposome binding (squares), E1
trimerization (circles), and fusion (triangles) are shown after
acidification to pH 5.75 at 20°C. To compare the kinetics of these
processes, the final extents of the relative values of the three
parameters were set to 100%. The absolute final extents were 30% for
SIN-liposome binding, 56% for E1 trimerization, and 14% for fusion.
In each case, SIN (0.5 µM viral phospholipid) was incubated with
liposomes (200 µM liposomal phospholipid) consisting of
PC/PE/SPM/Chol (molar ratio, 1.0:1.0:1.0:1.5) at pH 5.75 at 20°C.
SIN-liposome binding was determined as described in the legend for Fig.
6. E1 trimerization was determined as described in the legend for Fig.
7. Fusion was determined as described in the legend for Fig. 1.
|
|
 |
DISCUSSION |
The results of this study indicate that SIN has the capacity to
fuse efficiently in a model system involving liposomes as target
membranes. SIN-liposome fusion meets a stringent criterion for membrane
fusion, i.e., coalescence of the internal encapsulated compartments of
the interacting particles and a concomitant mixing of membrane lipids.
Coalescence of the viral and liposomal internal contents was assessed
on the basis of degradation of the viral core protein by trypsin
initially encapsulated in the liposomes (42, 58). Membrane
lipid mixing was monitored continuously by using two variants of a
fluorescence assay, based on incorporation of pyrene-labeled
phospholipids in either the viral or the liposomal membrane.
Incorporation of the probe into the viral membrane was achieved through
a biosynthetic labeling procedure, involving production of the virus
from cells cultured beforehand in the presence of pyrene-labeled fatty
acid. This methodology has been used before for labeling of SFV
(4, 42, 55) and tick-borne encephalitis virus
(11). The present results demonstrate that the procedure can
also be used reliably to produce pyrene-labeled SIN, without affecting
the infectivity of the virus.
SIN fuses efficiently with liposomes consisting of just phospholipids
and Chol, lacking a specific protein or carbohydrate receptor for virus
binding (Fig. 1 to 4). Furthermore, SIN-liposome fusion is strictly
dependent on low pH, fusion being optimal at pH 5.0 and undetectable at
neutral pH (Fig. 1 to 3). These characteristics of the fusion process
argue strongly in favor of a cell entry mechanism of SIN, involving
endocytosis of virus particles into endosomes and subsequent fusion of
the viral membrane with the endosomal membrane induced by the acidic pH
in the lumen of the endosomes. SIN shares the capacity to fuse to
receptor-free target liposomes with a number of other enveloped
viruses, such as influenza virus (51-53), SFV (4, 25,
55, 58), tick-borne encephalitis virus (11), and
vesicular stomatitis virus (41). In all cases, low pH
appears to be a necessary and sufficient condition for induction of the
fusion process. The efficient fusion of low-pH-dependent viruses with
receptor-free liposomes suggests that receptor binding is not a
mechanistic requirement for expression of membrane fusion activity by
these viruses. Receptor binding would appear to be primarily involved
in the initial binding of the viruses to the host cell and subsequent
endocytic uptake of the virus particles by the cell, although it cannot
be excluded that the receptor interaction also influences the detailed
characteristics of the subsequent fusion process from within the
endosome. In this respect, it is interesting that, in the case of SIN,
virus-receptor interaction has been found to result in conformational
alterations in the viral envelope glycoprotein, detected on the basis
of exposure of specific epitopes recognized by monoclonal antibodies
(17, 38). These conformational changes have been suggested
to be related to the viral fusion process. Clearly, our present results do not exclude that possibility. However, it would appear that low pH
is the essential trigger for fusion of SIN.
The conclusion that SIN infects its host cell by entry through
receptor-mediated endocytosis and fusion from within acidic endosomes
is in agreement with recent observations of Glomb-Reinmund and Kielian
(20). These investigators showed that the addition of weak
bases during cell entry of the virus efficiently inhibits translation
of viral RNA and infection. Previous studies had suggested that weak
bases would not inhibit cellular infection by SIN (7, 8).
Glomb-Reinmund and Kielian (20) also used balifomycin and
concanamycin, two reagents that prevent endosome acidification by a
mechanism different from that of weak bases, and again found that
cellular infection by SIN was inhibited, in further support of the
conclusion that the infection process involves acidic endosomes. Furthermore, the authors were unable to detect a specific role for
reduction of disulfide bridges through thiol-disulfide exchange reactions during the SIN entry process (20). It had been
suggested before that disulfide shuffling upon interaction of SIN with
its cell surface receptor would reorganize the viral spike to mediate virus cell entry through fusion with the plasma membrane (1, 5). Thus, the observations of Glomb-Reinmund and Kielian
(20) argue against fusion with the cell plasma membrane as
the physiological infection mechanism of SIN. Recently, DeTulleo and
Kirchhausen (12) also came to the conclusion that SIN does
not infect cells by plasma membrane fusion but rather through entry via
an endocytic pathway. Specifically, these investigators employed
expression of dominant-negative mutant forms of dynamin which inhibit
clathrin-dependent endocytosis and showed that these mutant dynamins
also inhibit cellular infection by SIN.
It is not clear what the explanation is for the above discrepancy
between the observations which suggest that SIN enters cells by plasma
membrane fusion and those that argue in favor of an endocytic entry
mechanism. One possibility, suggested by DeTulleo and Kirchhausen
(12) and Ferlenghi et al. (16), involves an undeliberate preexposure of the virus to low pH during freezing in cell
culture medium or PBS. This would induce a premature conformational change in the viral spike, allowing subsequent fusion of the virus with
the cell plasma membrane at neutral pH. Indeed, DeTulleo and
Kirchhausen (12) observed that SIN, frozen under such
inadequate buffering conditions, has the capacity to enter cells via a
clathrin-independent pathway, suggestive of fusion with the plasma
membrane. We were unable to detect any fusion of SIN at neutral pH,
whether or not the virus had been frozen beforehand in PBS or medium.
However, this does not rule out the possibility of fusion with the
plasma membrane at neutral pH of virus frozen under inadequate
buffering conditions, since a low degree of fusion (on the order of 1%
relative to the control) may well go unnoticed in our assay.
The characteristics of SIN fusion in the present liposomal model system
in many respects resemble those of SFV-liposome fusion (4, 42, 55,
59). Both viruses fuse with liposomes in a low-pH-dependent
manner, although we note that the pH optimum (pH 5.0) for fusion of the
AR339 strain of SIN used here is lower by about 0.5 pH unit than that
of SFV, in agreement with observations of Glomb-Reinmund and Kielian
(20). Also, for the Toto 1101 infectious clone of SIN, we
found a low pH optimum (pH 4.6) for fusion (49). In
cell-cell fusion studies, the pH optimum for SIN AR339 has been
reported to be 5.4 (2). Importantly, SIN, like SFV, requires
the presence of both Chol and sphingolipid in the target membrane (Fig.
4). Recently, in an elegant study, Lu et al. (34) have shown
that SIN entry into cells also requires Chol. In the liposome system,
Chol is essential for the initial low-pH-dependent binding of SFV to
target liposomes, while the sphingolipid appears to be involved
directly in the subsequent fusion reaction (42, 59).
Specifically, extensive irreversible binding of SFV occurs to liposomes
consisting of PC/PE/Chol, with fusion being undetectable; on the other
hand, virtually no binding (nor fusion) occurs with PC/PE/SPM liposomes
(42, 59). SIN appeared to behave in essentially the same
manner (Fig. 4 and 5), with virus binding to PC/PE or PC/PE/SPM
liposomes being at background level, and binding to PC/PE/Chol
liposomes reaching 25% (Fig. 5). On the other hand, the extent of
virus binding to PC/PE/Chol liposomes was limited compared to the
extent of virus binding to PC/PE/SPM/Chol liposomes (72%). One
explanation would be that the interaction of the virus with PC/PE/Chol
liposomes is not completely irreversible, such that in the absence of
fusion part of the virus may dissociate. In the presence of Chol and SPM in the liposomes, the interaction would become irreversible as a
result of fusion subsequent to binding. Indeed, all of the virus that
bound to liposomes containing both Chol and SPM at pH 5.0 at 37°C
appeared to be fused. Yet, even under these optimal conditions, a small
fraction of the virus does not seem to interact at all with the
liposomes. It is possible that, upon exposure of the virus-liposome
mixture to low pH, part of the virus may become inactivated so rapidly
that it does not have the opportunity to productively interact with the liposomes.
The results shown in Fig. 7 demonstrate that under fusion conditions,
the E1 component of the SIN spike forms a homotrimeric structure, while
at the same time E1 becomes trypsin resistant. The relative kinetics of
the E1 trimer formation and the appearance of the trypsin-resistant
phenotype suggest that the E1 homotrimer and the trypsin-resistant form
of E1 are in fact identical structures. By analogy to the role of the
E1 trimer in SFV fusion (4, 25, 55), we propose that the SIN
E1 homotrimer represents the fusion-active conformation of the viral
spike. The kinetics of virus-liposome binding and E1 homotrimer
formation are indistinguishable (Fig. 8). For SFV, on the basis of
early results, we have suggested that E1 homotrimer formation precedes
virus-liposome binding (4). However, more recent
observations involving selective inhibition of SFV E1 trimerization
with Zn2+ ions (10) or through a mutation in the
E1 protein (28) have shown that dissociation of the E2/E1
heterodimer at low pH suffices for initiation of virus-liposome binding
and that E1 trimer formation occurs after the binding of the virus to
the liposomes (10, 28). The results shown for SIN in Fig. 8
are in agreement with this notion. Therefore, it would appear that E1
trimer formation is facilitated by the association of the virus with
the liposomes, trimerization occurring without any significant delay
after the initial binding process. Under the conditions of the
experiment (pH 5.75, 20°C), fusion then proceeds after a lag period.
This lag presumably represents the time required for additional
rearrangements within or between homotrimeric E1 spikes. We propose
that the target membrane sphingolipid is critically involved in this
step, leading to the actual fusion-active structure of the virus.
 |
ACKNOWLEDGMENTS |
This work was supported by the U.S. National Institutes of Health
(grant HL 16660) and by The Netherlands Organization for Scientific
Research (NWO) under the auspices of the Foundation for Chemical
Research (CW).
We thank Diane E. Griffin (Johns Hopkins University) for generously
providing the Sindbis virus AR339 stock.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Groningen, Department of Physiological Chemistry, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands. Phone: 31 50 3632733. Fax: 31 50 3632728. E-mail: J.C.Wilschut{at}med.rug.nl.
 |
REFERENCES |
| 1.
|
Abell, B. A., and D. T. Brown.
1993.
Sindbis virus membrane fusion is mediated by reduction of glycoprotein disulfide bridges at the cell surface.
J. Virol.
67:5496-5501[Abstract/Free Full Text].
|
| 2.
|
Boggs, W. M.,
C. S. Hahn,
E. G. Strauss,
J. H. Strauss, and D. E. Griffin.
1989.
Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein.
Virology
169:485-488[Medline].
|
| 3.
|
Böttcher, C. J. F.,
C. M. van Gent, and C. Fries.
1961.
A rapid and sensitive sub-micro phosphorus determination.
Anal. Chim. Acta
24:203-204.
|
| 4.
|
Bron, R.,
J. M. Wahlberg,
H. Garoff, and J. Wilschut.
1993.
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein.
EMBO J.
12:693-701[Medline].
|
| 5.
|
Brown, D. T., and J. Edwards.
1992.
Structural changes in alphaviruses accompanying the process of membrane penetration.
Semin. Virol.
3:519-527.
|
| 6.
|
Byrnes, A. P., and D. E. Griffin.
1998.
Binding of Sindbis virus to cell surface heparan sulfate.
J. Virol.
72:7349-7356[Abstract/Free Full Text].
|
| 7.
|
Cassell, S.,
J. Edwards, and D. T. Brown.
1984.
Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.
J. Virol.
52:857-864[Abstract/Free Full Text].
|
| 8.
|
Coombs, K.,
E. Mann,
J. Edwards, and D. T. Brown.
1981.
Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus.
J. Virol.
37:1060-1065[Abstract/Free Full Text].
|
| 9.
|
Corver, J.,
L. Moesby,
R. K. Erukulla,
K. C. Reddy,
R. Bittman, and J. Wilschut.
1995.
Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone.
J. Virol.
69:3220-3223[Abstract].
|
| 10.
|
Corver, J.,
R. Bron,
H. Snippe,
C. Kraaijeveld, and J. Wilschut.
1997.
Membrane fusion activity of Semliki Forest virus in a liposomal model system: specific inhibition by Zn2+ ions.
Virology
238:14-21[Medline].
|
| 11.
| Corver, J., A. Ortiz, S. L. Allison, J. Schalich,
F. X. Heinz, and J. Wilschut. Membrane fusion activity of
tick-borne encephalitis virus and recombinant subviral particles in a
liposomal model system. Submitted for publication.
|
| 12.
|
DeTulleo, L., and T. Kirchhausen.
1998.
The clathrin endocytic pathway in viral infection.
EMBO J.
17:4585-4593[Medline].
|
| 13.
|
Edwards, J.,
E. Mann, and D. T. Brown.
1983.
Conformational changes in Sindbis virus envelope protein accompanying exposure to low pH.
J. Virol.
45:1090-1097[Abstract/Free Full Text].
|
| 14.
|
Edwards, J., and D. T. Brown.
1991.
Sindbis virus infection of a Chinese hamster ovary cell mutant defective in the acidification of endosomes.
Virology
182:28-33[Medline].
|
| 15.
|
Fan, D. P., and B. M. Sefton.
1978.
The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus.
Cell
15:985-992[Medline].
|
| 16.
|
Ferlenghi, I.,
B. Gowen,
F. de Haas,
E. J. Mancini,
H. Garoff,
M. Sjöberg, and S. D. Fuller.
1998.
The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spike.
J. Mol. Biol.
283:71-81[Medline].
|
| 17.
|
Flynn, D. C.,
W. J. Meyer,
J. M. Mackenzie, and R. E. Johnston.
1990.
A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction.
J. Virol.
64:3643-3653[Abstract/Free Full Text].
|
| 18.
|
Galla, H. J., and W. Hartmann.
1974.
Excimer forming lipids in membrane research.
Chem. Phys. Lipids
27:199-219.
|
| 19.
|
Garoff, H.,
A. M. Frischauf,
K. Simons,
H. Lehrach, and H. Delius.
1980.
Nucleotide sequence of cDNA coding for Semliki Forest virus membrane glycoproteins.
Nature
288:236-241[Medline].
|
| 20.
|
Glomb-Reinmund, S., and M. Kielian.
1998.
The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus.
Virology
248:372-381[Medline].
|
| 21.
|
Helenius, A.,
J. Kartenbeck,
K. Simons, and E. Fries.
1980.
On the entry of Semliki Forest virus into BHK-21 cells.
J. Cell Biol.
84:404-420[Abstract/Free Full Text].
|
| 22.
|
Helenius, A.
1984.
Semliki Forest virus penetration from endosomes: a morphological study.
Biol. Cell
51:181-187[Medline].
|
| 23.
|
Hernandez, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Dev. Biol.
12:627-661[Medline].
|
| 24.
|
Izurun, A.,
L. Nieva, and L. Carrasco.
1997.
Entry of Semliki Forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection.
Virology
227:488-492[Medline].
|
| 25.
|
Justman, J.,
M. R. Klimjack, and M. Kielian.
1993.
Role of spike protein conformational changes in fusion of Semliki Forest virus.
J. Virol.
67:7597-7607[Abstract/Free Full Text].
|
| 26.
|
Kielian, M., and A. Helenius.
1984.
Role of cholesterol in fusion of Semliki Forest virus with membranes.
J. Virol.
52:281-283[Abstract/Free Full Text].
|
| 27.
|
Kielian, M.
1995.
Membrane fusion and the alphavirus life cycle.
Adv. Virus Res.
45:113-151[Medline].
|
| 28.
|
Kielian, M.,
M. R. Klimjack,
S. Ghosh, and W. A. Duffus.
1996.
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.
J. Cell Biol.
134:863-872[Abstract/Free Full Text].
|
| 29.
|
Klimjack, M. R.,
S. Jeffrey, and M. Kielian.
1994.
Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein.
J. Virol.
68:6940-6946[Abstract/Free Full Text].
|
| 30.
|
Klimstra, W. B.,
K. D. Ryman, and R. E. Johnston.
1998.
Adaptation of Sindbis virus to BHK-21 cells selects for use of heparan sulfate as an attachment receptor.
J. Virol.
72:7357-7366[Abstract/Free Full Text].
|
| 31.
|
Levy Mintz, P., and M. Kielian.
1991.
Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.
J. Virol.
65:4292-4300[Abstract/Free Full Text].
|
| 32.
| Li, G., P. Schoen, J. M. Smit, L. C. Bijl, J. Corver, K. Lin, and J. Wilschut. Retention of internal aqueous
contents during fusion of Semliki Forest virus with liposomes.
Submitted for publication.
|
| 33.
|
Lobigs, M., and H. Garoff.
1990.
Fusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62.
J. Virol.
64:5214-5218[Abstract/Free Full Text].
|
| 34.
|
Lu, Y. E.,
T. Cassese, and M. Kielian.
1999.
The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence.
J. Virol.
73:4272-4278[Abstract/Free Full Text].
|
| 35.
|
Marsh, M.,
J. Wellsteed,
H. Kern,
E. Harms, and A. Helenius.
1982.
Monensin inhibits Semliki Forest virus penetration into culture cells.
Proc. Natl. Acad. Sci. USA
79:5297-5301[Abstract/Free Full Text].
|
| 36.
|
Marsh, M.,
E. Bolzau, and A. Helenius.
1983.
Penetration of Semliki Forest virus from acidic prelysosomal vacuoles.
Cell
32:931-940[Medline].
|
| 37.
|
Mayne, J. T.,
C. M. Rice,
E. G. Strauss,
M. W. Hunkapiller, and J. H. Strauss.
1984.
Biochemical studies of the maturation of the small Sindbis virus glycoprotein E3.
Virology
134:338-357[Medline].
|
| 38.
|
Meyer, W. J.,
S. Gidwitz,
V. K. Ayers,
R. J. Schoepp, and R. E. Johnston.
1992.
Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH.
J. Virol.
66:3504-3513[Abstract/Free Full Text].
|
| 39.
|
Moehring, J. M., and T. J. Moehring.
1983.
Strains of CHO-K1 cells resistant to Pseudomonas exotoxin A and cross-resistant to diphtheria toxin and viruses.
Infect. Immun.
41:998-1009[Abstract/Free Full Text].
|
| 40.
|
Moesby, L.,
J. Corver,
R. K. Erukulla,
R. Bittman, and J. Wilschut.
1995.
Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner.
Biochemistry
34:10319-10324[Medline].
|
| 41.
|
Moor, A. C. E.,
A. E. Wagenaars-van Gompel,
R. C. A. Hermans,
J. van der Meulen,
J. M. Smit,
J. Wilschut,
A. Brand,
T. M. A. R. Dubbelman, and J. VanSteveninck.
1999.
Inhibition of various steps in the replication cycle of vesicular stomatitis virus contributes to its photoinactivation by AlPcS4 or Pc4 and red light.
Photochem. Photobiol.
69:353-359[Medline].
|
| 42.
|
Nieva, J. L.,
R. Bron,
J. Corver, and J. Wilschut.
1994.
Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane.
EMBO J.
13:2797-2804[Medline].
|
| 43.
|
Pal, R.,
Y. Barenholz, and R. R. Wagner.
1988.
Pyrene phospholipid as a biological fluorescent probe for studying fusion of virus membrane with liposomes.
Biochemistry
27:30-36[Medline].
|
| 44.
|
Peterson, G. L.
1977.
A simplification of the protein assay method of Lowry et al. which is more generally applicable.
Anal. Biochem.
83:346-356[Medline].
|
| 45.
|
Phalen, T., and M. Kielian.
1991.
Cholesterol is required for infection by Semliki Forest virus.
J. Cell Biol.
112:615-623[Abstract/Free Full Text].
|
| 46.
|
Rice, C. M., and J. H. Strauss.
1981.
Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins.
Proc. Natl. Acad. Sci. USA
78:2062-2066[Abstract/Free Full Text].
|
| 47.
|
Robbins, A. R.,
C. Oliver,
J. L. Bateman,
S. S. Krag,
C. J. Galloway, and I. Mellman.
1984.
A single mutation in Chinese hamster ovary cells impairs both Golgi and endosomal functions.
J. Cell Biol.
99:1296-1308[Abstract/Free Full Text].
|
| 48.
|
Salminen, A.,
J. W. Wahlberg,
M. Lobigs,
P. Liljeström, and H. Garoff.
1992.
Membrane fusion process of Semliki Forest virus II: cleavage-dependent reorganization of the spike protein complex controls virus entry.
J. Cell Biol.
116:349-357[Abstract/Free Full Text].
|
| 49.
| Smit, J. M., and J. Wilschut. Unpublished
data.
|
| 50.
|
Smith, T. J.,
R. H. Cheng,
N. H. Olson,
P. Peterson,
E. Chase,
R. J. Kuhn, and T. S. Baker.
1995.
Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy.
Proc. Natl. Acad. Sci. USA
92:10648-10652[Abstract/Free Full Text].
|
| 51.
|
Stegmann, T.,
D. Hoekstra,
G. Scherphof, and J. Wilschut.
1986.
Fusion activity of influenza virus: a comparison between biological and artificial target membrane vesicles.
J. Biol. Chem.
261:10966-10969[Abstract/Free Full Text].
|
| 52.
|
Stegmann, T.,
S. Nir, and J. Wilschut.
1989.
Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes.
Biochemistry
28:1698-1704[Medline].
|
| 53.
|
Stegmann, T.,
J. M. White, and A. Helenius.
1990.
Intermediates in influenza induced membrane fusion.
EMBO J.
9:4231-4241[Medline].
|
| 54.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 55.
|
Wahlberg, J. M.,
R. Bron,
J. Wilschut, and H. Garoff.
1992.
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.
J. Virol.
66:7309-7318[Abstract/Free Full Text].
|
| 56.
|
Wahlberg, J. M., and H. Garoff.
1992.
Membrane fusion process of Semliki Forest virus. I. Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells.
J. Cell Biol.
116:339-348[Abstract/Free Full Text].
|
| 57.
|
Wang, K. S.,
R. J. Kuhn,
E. G. Strauss,
S. Ou, and J. H. Strauss.
1992.
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells.
J. Virol.
66:4992-5001[Abstract/Free Full Text].
|
| 58.
|
White, J., and A. Helenius.
1980.
pH-dependent fusion between the Semliki Forest virus membrane and liposomes.
Proc. Natl. Acad. Sci. USA
77:3273-3277[Abstract/Free Full Text].
|
| 59.
|
Wilschut, J.,
J. Corver,
J. L. Nieva,
R. Bron,
L. Moesby,
K. C. Reddy, and R. Bittman.
1995.
Fusion of Semliki Forest virus with cholesterol-containing liposomes at low pH: a specific requirement for sphingolipids.
Mol. Membr. Biol.
12:143-149[Medline].
|
Journal of Virology, October 1999, p. 8476-8484, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vogt, M. R., Moesker, B., Goudsmit, J., Jongeneelen, M., Austin, S. K., Oliphant, T., Nelson, S., Pierson, T. C., Wilschut, J., Throsby, M., Diamond, M. S.
(2009). Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step. J. Virol.
83: 6494-6507
[Abstract]
[Full Text]
-
Haid, S., Pietschmann, T., Pecheur, E.-I.
(2009). Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles. J. Biol. Chem.
284: 17657-17667
[Abstract]
[Full Text]
-
Ng, C. G., Coppens, I., Govindarajan, D., Pisciotta, J., Shulaev, V., Griffin, D. E.
(2008). Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity. Proc. Natl. Acad. Sci. USA
105: 16326-16331
[Abstract]
[Full Text]
-
Umashankar, M., Sanchez-San Martin, C., Liao, M., Reilly, B., Guo, A., Taylor, G., Kielian, M.
(2008). Differential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion Properties. J. Virol.
82: 9245-9253
[Abstract]
[Full Text]
-
Lee, C.-J., Lin, H.-R., Liao, C.-L., Lin, Y.-L.
(2008). Cholesterol Effectively Blocks Entry of Flavivirus. J. Virol.
82: 6470-6480
[Abstract]
[Full Text]
-
van der Schaar, H. M., Rust, M. J., Waarts, B.-L., van der Ende-Metselaar, H., Kuhn, R. J., Wilschut, J., Zhuang, X., Smit, J. M.
(2007). Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking. J. Virol.
81: 12019-12028
[Abstract]
[Full Text]
-
Ng, C. G., Griffin, D. E.
(2006). Acid Sphingomyelinase Deficiency Increases Susceptibility to Fatal Alphavirus Encephalomyelitis. J. Virol.
80: 10989-10999
[Abstract]
[Full Text]
-
Lavillette, D., Bartosch, B., Nourrisson, D., Verney, G., Cosset, F.-L., Penin, F., Pecheur, E.-I.
(2006). Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes. J. Biol. Chem.
281: 3909-3917
[Abstract]
[Full Text]
-
Clark, K. M., Wetzel, J. D., Gu, Y., Ebert, D. H., McAbee, S. A., Stoneman, E. K., Baer, G. S., Zhu, Y., Wilson, G. J., Prasad, B. V. V., Dermody, T. S.
(2006). Reovirus Variants Selected for Resistance to Ammonium Chloride Have Mutations in Viral Outer-Capsid Protein {sigma}3. J. Virol.
80: 671-681
[Abstract]
[Full Text]
-
Waarts, B.-L., Smit, J. M., Aneke, O. J. C., McInerney, G. M., Liljestrom, P., Bittman, R., Wilschut, J.
(2005). Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus. J. Virol.
79: 7942-7948
[Abstract]
[Full Text]
-
Zaitseva, E., Mittal, A., Griffin, D. E., Chernomordik, L. V.
(2005). Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. JCB
169: 167-177
[Abstract]
[Full Text]
-
Stiasny, K., Heinz, F. X.
(2004). Effect of Membrane Curvature-Modifying Lipids on Membrane Fusion by Tick-Borne Encephalitis Virus. J. Virol.
78: 8536-8542
[Abstract]
[Full Text]
-
Stiasny, K., Koessl, C., Heinz, F. X.
(2003). Involvement of Lipids in Different Steps of the Flavivirus Fusion Mechanism. J. Virol.
77: 7856-7862
[Abstract]
[Full Text]
-
Chazal, N., Gerlier, D.
(2003). Virus Entry, Assembly, Budding, and Membrane Rafts. Microbiol. Mol. Biol. Rev.
67: 226-237
[Abstract]
[Full Text]
-
Earp, L. J., Delos, S. E., Netter, R. C., Bates, P., White, J. M.
(2003). The Avian Retrovirus Avian Sarcoma/Leukosis Virus Subtype A Reaches the Lipid Mixing Stage of Fusion at Neutral pH. J. Virol.
77: 3058-3066
[Abstract]
[Full Text]
-
Wengler, G., Koschinski, A., Wengler, G., Dreyer, F.
(2003). Entry of alphaviruses at the plasma membrane converts the viral surface proteins into an ion-permeable pore that can be detected by electrophysiological analyses of whole-cell membrane currents. J. Gen. Virol.
84: 173-181
[Abstract]
[Full Text]
-
Samsonov, A. V., Chatterjee, P. K., Razinkov, V. I., Eng, C. H., Kielian, M., Cohen, F. S.
(2002). Effects of Membrane Potential and Sphingolipid Structures on Fusion of Semliki Forest Virus. J. Virol.
76: 12691-12702
[Abstract]
[Full Text]
-
Chatterjee, P. K., Eng, C. H., Kielian, M.
(2002). Novel Mutations That Control the Sphingolipid and Cholesterol Dependence of the Semliki Forest Virus Fusion Protein. J. Virol.
76: 12712-12722
[Abstract]
[Full Text]
-
Waarts, B.-L., Bittman, R., Wilschut, J.
(2002). Sphingolipid and Cholesterol Dependence of Alphavirus Membrane Fusion. LACK OF CORRELATION WITH LIPID RAFT FORMATION IN TARGET LIPOSOMES. J. Biol. Chem.
277: 38141-38147
[Abstract]
[Full Text]
-
Smit, J. M., Waarts, B.-L., Kimata, K., Klimstra, W. B., Bittman, R., Wilschut, J.
(2002). Adaptation of Alphaviruses to Heparan Sulfate: Interaction of Sindbis and Semliki Forest Viruses with Liposomes Containing Lipid-Conjugated Heparin. J. Virol.
76: 10128-10137
[Abstract]
[Full Text]
-
Guyader, M., Kiyokawa, E., Abrami, L., Turelli, P., Trono, D.
(2002). Role for Human Immunodeficiency Virus Type 1 Membrane Cholesterol in Viral Internalization. J. Virol.
76: 10356-10364
[Abstract]
[Full Text]
-
Lee, P., Knight, R., Smit, J. M., Wilschut, J., Griffin, D. E.
(2002). A Single Mutation in the E2 Glycoprotein Important for Neurovirulence Influences Binding of Sindbis Virus to Neuroblastoma Cells. J. Virol.
76: 6302-6310
[Abstract]
[Full Text]
-
Diefenbach, R. J., Miranda-Saksena, M., Diefenbach, E., Holland, D. J., Boadle, R. A., Armati, P. J., Cunningham, A. L.
(2002). Herpes Simplex Virus Tegument Protein US11 Interacts with Conventional Kinesin Heavy Chain. J. Virol.
76: 3282-3291
[Abstract]
[Full Text]
-
Smit, J. M., Klimstra, W. B., Ryman, K. D., Bittman, R., Johnston, R. E., Wilschut, J.
(2001). PE2 Cleavage Mutants of Sindbis Virus: Correlation between Viral Infectivity and pH-Dependent Membrane Fusion Activation of the Spike Heterodimer. J. Virol.
75: 11196-11204
[Abstract]
[Full Text]
-
Morizono, K., Bristol, G., Xie, Y.-m., Kung, S. K.-P., Chen, I. S. Y.
(2001). Antibody-Directed Targeting of Retroviral Vectors via Cell Surface Antigens. J. Virol.
75: 8016-8020
[Abstract]
[Full Text]
-
Niyogi, K., Hildreth, J. E. K.
(2001). Characterization of New Syncytium-Inhibiting Monoclonal Antibodies Implicates Lipid Rafts in Human T-Cell Leukemia Virus Type 1 Syncytium Formation. J. Virol.
75: 7351-7361
[Abstract]
[Full Text]
-
Hug, P., Lin, H.-M. J., Korte, T., Xiao, X., Dimitrov, D. S., Wang, J. M., Puri, A., Blumenthal, R.
(2000). Glycosphingolipids Promote Entry of a Broad Range of Human Immunodeficiency Virus Type 1 Isolates into Cell Lines Expressing CD4, CXCR4, and/or CCR5. J. Virol.
74: 6377-6385
[Abstract]
[Full Text]